The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Gene Review

UL23  -  thymidine kinase

Macacine herpesvirus 1

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of UL23

  • We also report that, in mice and rabbits in vivo, the compound is effective against both local and systemic infections with herpes simplex virus type 1, including herpetic keratitis caused by a TK- mutant which is resistant to the classical anti-herpes drugs [1].
  • Chicken ovalbumin gene fused to a herpes simplex virus alpha promoter and linked to a thymidine kinase gene is regulated like a viral gene [2].
  • The cellular localization of the precore/core and core proteins was studied by immunofluorescence following transfection of 143 thymidine kinase-negative (TK ) and Hep-G2 cells with expression constructs containing wild-type (hepatitis B e antigen [HBeAg]-positive) and precore mutant (HBeAg-negative) sequences [3].
  • For suicide gene therapy, VP22 activity was demonstrated under hypoxia by coupling VP22 to the HSV thymidine kinase (HSVtk) [4].
  • (iii) HSV-1(HFEM)tsB7 induced the alpha-TK gene chimeras at the nonpermissive (39 degrees C) temperature; at 39 degrees C the parental HSV-1(HFEM)tsB7 capsids accumulate at nuclear pores and do not release viral DNA [5].
 

High impact information on UL23

  • The therapeutic effect is achieved by the selective killing of thymidine kinase gene-modified activated T cells by ganciclovir (GCV) [6].
  • Here, we aimed to determine whether an immunopathological process induced by a viral infection could be controlled by GCV when T cells express a thymidine kinase transgene [6].
  • From this, we conclude that proteins that bind TK and facilitate its cytoplasmic accumulation do not travel through a CRM1-dependent RNA transport pathway [7].
  • Multiple cis-acting RNA sequences, or subelements, that induce cytoplasmic localization of unspliced RNA were mapped within the TK gene [7].
  • Furthermore, like HBV PRE-containing RNA, TK cytoplasmic localization is not sensitive to leptomycin B, a drug that inhibits the export of proteins containing nuclear export signals [7].
 

Chemical compound and disease context of UL23

 

Biological context of UL23

  • Cloned HSV DNA fragments derived from various parts of the genome were cotransfected into BHK cells together with chimaeric plasmids which contained the thymidine kinase gene under IE control [11].
  • This enhancer potentiates a marked increased activity from the heterologous thymidine kinase promoter in an orientation-independent manner and at a proximal, as well as a distal, location [12].
  • (Cell 24:555-565, 1981) have shown that chimeric genes constructed by fusion of 5' noncoding leader and upstream sequences of alpha genes to the 5' noncoding leader and structural sequences of the viral thymidine kinase (TK), a beta gene, are regulated as alpha genes upon recombination into the viral genome [5].
  • We identified cis-acting elements in the intronless herpes simplex virus type 1 thymidine kinase (TK) gene that facilitate intron-independent gene expression [7].
  • In cells converted from TK- to TK+ phenotype, these chimeric genes are induced by infection with homologous TK- virus [5].
 

Associations of UL23 with chemical compounds

  • Compound 26b competitively inhibited TK-2 with respect to thymidine and uncompetitively with respect to ATP [8].
  • N1-substituted thymine derivatives as mitochondrial thymidine kinase (TK-2) inhibitors [8].
  • Compounds with a hexamethylene spacer (18, 26b, 31) displayed the highest inhibitory values against TK-2 (IC50 = 0.3-0.5 microM) [8].
  • RESULTS: The acyclovir-resistant virus, with a Thr63Ile change in the ATP-binding site of the thymidine kinase gene, produced almost as many skin lesions as the wild-type susceptible virus [13].
  • This differs from the results for CV where only idoxuridine and bromodeoxyuridine appeared to be activated, putatively by the type II TK expressed by this virus [14].
 

Analytical, diagnostic and therapeutic context of UL23

  • (iv) The alpha-TK gene chimeras were not induced by infection with spontaneous TK- mutants of pseudorabies virus and bovine mammillitis virus or with human cytomegalovirus or adenovirus type 2 or by exposure to lysates of HSV-1-infected cells from which the virus was removed by centrifugation [5].
  • We used a variety of techniques, including two-color flow cytometry and cytotoxicity assays to detect the presence of TK in the non-producing cells [15].

References

  1. A novel selective broad-spectrum anti-DNA virus agent. De Clercq, E., Holý, A., Rosenberg, I., Sakuma, T., Balzarini, J., Maudgal, P.C. Nature (1986) [Pubmed]
  2. Chicken ovalbumin gene fused to a herpes simplex virus alpha promoter and linked to a thymidine kinase gene is regulated like a viral gene. Post, L.E., Norrild, B., Simpson, T., Roizman, B. Mol. Cell. Biol. (1982) [Pubmed]
  3. The precore sequence of hepatitis B virus is required for nuclear localization of the core protein. Aiba, N., McGarvey, M.J., Waters, J., Hadziyannis, S.J., Thomas, H.C., Karayiannis, P. Hepatology (1997) [Pubmed]
  4. VP22-mediated intercellular transport for suicide gene therapy under oxic and hypoxic conditions. Greco, O., Joiner, M.C., Doleh, A., Scott, S.D. Gene Ther. (2005) [Pubmed]
  5. Characterization of the herpes simplex virion-associated factor responsible for the induction of alpha genes. Batterson, W., Roizman, B. J. Virol. (1983) [Pubmed]
  6. Transient control of a virus-induced immunopathology by genetic immunosuppression. Boyer, O., Cohen, J.L., Bellier, B., Thomas-Vaslin, V., Klatzmann, D., Saron, M.F. Gene Ther. (2000) [Pubmed]
  7. Splicing-independent expression of the herpes simplex virus type 1 thymidine kinase gene is mediated by three cis-acting RNA subelements. Otero, G.C., Hope, T.J. J. Virol. (1998) [Pubmed]
  8. N1-substituted thymine derivatives as mitochondrial thymidine kinase (TK-2) inhibitors. Hernandez, A.I., Familiar, O., Negri, A., Rodríguez-Barrios, F., Gago, F., Karlsson, A., Camarasa, M.J., Balzarini, J., Pérez-Pérez, M.J. J. Med. Chem. (2006) [Pubmed]
  9. Thymidine kinase mutations conferring acyclovir resistance in herpes simplex type 1 recombinant viruses. Sergerie, Y., Boivin, G. Antimicrob. Agents Chemother. (2006) [Pubmed]
  10. Reactivation of acyclovir-resistant thymidine kinase-deficient herpes simplex virus harbouring single base insertion within a 7 Gs homopolymer repeat of the thymidine kinase gene. Morfin, F., Thouvenot, D., Aymard, M., Souillet, G. J. Med. Virol. (2000) [Pubmed]
  11. Identification of herpes simplex virus DNA sequences which encode a trans-acting polypeptide responsible for stimulation of immediate early transcription. Campbell, M.E., Palfreyman, J.W., Preston, C.M. J. Mol. Biol. (1984) [Pubmed]
  12. Identification of a strong enhancer element upstream from the pregenomic RNA start site of the duck hepatitis B virus genome. Crescenzo-Chaigne, B., Pillot, J., Lilienbaum, A., Levrero, M., Elfassi, E. J. Virol. (1991) [Pubmed]
  13. Pathogenicity and response to topical antiviral therapy in a murine model of acyclovir-sensitive and acyclovir-resistant herpes simplex viruses isolated from the same patient. Lebel, A., Boivin, G. J. Clin. Virol. (2006) [Pubmed]
  14. Distinct thymidine kinases encoded by cowpox virus and herpes simplex virus contribute significantly to the differential antiviral activity of nucleoside analogs. Prichard, M.N., Williams, A.D., Keith, K.A., Harden, E.A., Kern, E.R. Antiviral Res. (2006) [Pubmed]
  15. Fusion of herpes simplex virus thymidine kinase to VP22 does not result in intercellular trafficking of the protein. Beerens, A.M., Rots, M.G., de Vries, E.F., Haisma, H.J. Int. J. Mol. Med. (2007) [Pubmed]
 
WikiGenes - Universities